NARP syndrome and adult-onset generalised seizures

Epileptic Disorders

Volumn 8, Issue 3, 2006, Pages 200-203

  Keränen, Tapani ^a   Kuusisto, Hanna ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adult; Epilepsy; Generalised; Mitochondrial disease; NARP; Retinitis pigmentosa

Indexed keywords

DIAZEPAM; LAMOTRIGINE; VALPROIC ACID;

ARTICLE; ATAXIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; FEMALE; GENE MUTATION; HUMAN; MUSCLE WEAKNESS; NARP SYNDROME; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; SEIZURE; VISUAL ACUITY; VISUAL DISORDER;

ADULT; ATAXIA; ATROPHY; BRAIN; CEREBELLUM; ELECTROENCEPHALOGRAPHY; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE WEAKNESS; RETINITIS PIGMENTOSA; STATUS EPILEPTICUS; SYNDROME; VISION DISORDERS;

EID: 33749596336     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ciafaloni E, Santorelli FM, Shanske S, et al. Maternally inherited Leigh syndrome. J Pediatr 1993; 122: 419-22.
2. Desguerre J, Pinton F, Nabbout R, et al. Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation. Neuropediatrics 2003; 34: 265-9.
3. Fryer A, Appleton R, Sweeney MG, et al. Mitochondrial DNA 8993 (NARP) mutation presenting with a heterogeneous phenotype including 'cerebral palsy'. Arch Dis Child 1994; 71: 419-22.
4. Holt IJ, Harding AE, Petty RK, et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990; 46: 428-33.
5. Mäkelä-Bengs P, Suomalainen A, Majander A, et al. Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome. Pediatr Res 1995; 37: 634-9.
6. Ortiz RG, Newman NJ, Shoffner JM, et al. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch Ophthalmol 1993; 111: 1525-30.
7. Parfait B, de Lonlay P, von Kleist-Retzow JC, et al. The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia. Eur J Pediatr 1999; 158: 55-8.
8. Puddu P, Barboni P, Mantovani V, et al. Retinitis pigmentosa, ataxia, and mental retardation associated with mitochondrial DNA mutation in an Italian family. Br J Ophthalmol 1993; 77: 84-8.
9. Santorelli FM, Tanji K, Shanske S, et al. Heterogeneous clinical presentation of the mtDNA NARP/T8993C mutation. Neurology 1997; 49: 270-3.
10. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992; 50: 852-8.
11. Tatuch Y, Pagon RA, Vlcek B, et al. The 8993 mtDNA mutation: heteroplasmy and clinical presentation in three families. Eur J Hum Genet 1994; 2: 35-43.
12. Uziel G, Moroni I, Lamantea E, et al. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 1997; 63: 16-22.